ConductScience.org, home

Library / Genes

IL17F: interleukin 17F

1 protein, 305 patents, 2 drugs, 52 trials, 3,466 NIH grants and 6,992 papers.

Gene 7

Its symbol and name are HGNC's, unless HGNC and NCBI Gene contradict each other.

FieldValueSource
SymbolIL17FHGNC
Nameinterleukin 17FHGNC
NCBI Gene ID112744NCBI Gene
HGNC IDHGNC:16404HGNC
EnsemblENSG00000112116NCBI Gene
AliasesCANDF6, IL-17F, ML-1, ML1NCBI Gene
Typeprotein-codingNCBI Gene

Proteins 1

Reviewed human proteins whose Swiss-Prot entry states the gene.

UniProt entryProteinLengthStructuresGene stated inSource
Q96PD4Interleukin-17F1639Ensembl, GeneID, HGNCUniProt

Patents 305

Patents whose sequence listing holds the protein exactly: the same sequence, by SHA-256, length and CRC-64. A sequence a patent lists is not always one it claims.

PublicationPublishedSEQ ID NOProteinSource
EP 4731677 A22026-04-2988Q96PD4Espacenet
EP 4650780 A22025-11-196275Q96PD4Espacenet
US 12473363 B22025-11-18912Q96PD4Espacenet
EP 4640849 A22025-10-29906Q96PD4Espacenet
EP 4641201 A22025-10-296038Q96PD4Espacenet
EP 4641203 A22025-10-29188Q96PD4Espacenet
JP 2025147176 A2025-10-066905Q96PD4Espacenet
JP 2025529142 A2025-09-046705Q96PD4Espacenet
EP 4591879 A22025-07-3038Q96PD4Espacenet
US 12371689 B22025-07-296705Q96PD4Espacenet

Drugs 2

Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.

DrugChEMBL IDMechanismActionSource
BIMEKIZUMABCHEMBL4297700Interleukin-17F inhibitorINHIBITORChEMBL
M-1095CHEMBL4298023Interleukin-17F inhibitorINHIBITORChEMBL

Trials 52

Trials of those drugs. A trial joins the gene only through a drug that acts on it.

TrialDrugPhaseResults first postedSource
NCT07290036BIMEKIZUMABPHASE1ClinicalTrials.gov
NCT07223138M-1095PHASE3ClinicalTrials.gov
NCT07219420BIMEKIZUMABPHASE3ClinicalTrials.gov
NCT07007637M-1095PHASE3ClinicalTrials.gov
NCT06921850BIMEKIZUMABPHASE3ClinicalTrials.gov
NCT06786936BIMEKIZUMABClinicalTrials.gov
NCT06768671M-1095PHASE3ClinicalTrials.gov
NCT06742333BIMEKIZUMABPHASE2ClinicalTrials.gov
NCT06668181BIMEKIZUMABPHASE3ClinicalTrials.gov
NCT06641089M-1095PHASE3ClinicalTrials.gov

NIH grants 3466

NIH projects whose papers are about the gene, through NIH's grant-paper links.

ProjectTitleIts papers about the geneNewest fiscal yearSource
UL1TR001866Developing, Demonstrating, and Disseminating Innovative Programs to Achieve Translational Success412,025NIH's project files
R01AI127564Genome-wide search for inborn errors of IL-17 immunity underlying chronic mucocutaneous candidiasis242,025NIH's project files
ZIAAI001065India International Center for Excellence in Research212,025NIH's project files
R37DE022550Host and Fungal Regulation of Type 17 Immunity to Oral Candidiasis162,025NIH's project files
ZIAAI000647Genes And Gene Products As Immunoadjuvants162,025NIH's project files
ZIAAI000646Transgenic Animal Models Of Human Immune Defects152,025NIH's project files
ZIAAI001175Immunopathogenesis of Fungal Infections152,025NIH's project files
P30CA008748Cancer Center Support Grant132,025NIH's project files
P30CA016672Cancer Center Support Grant132,025NIH's project files
ZIAAR041159Cytokine Signaling, Immunoregulation and Autoimmune and Immunodeficiency Diseases132,025NIH's project files

Papers 6992

Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.

PMIDFound bySource
42822776PubTator, text miningPubMed
42813258PubTator, text miningPubMed
42798904PubTator, text miningPubMed
42785396PubTator, text miningPubMed
42782368PubTator, text miningPubMed
42780753PubTator, text miningPubMed
42772563PubTator, text miningPubMed
42751973PubTator, text miningPubMed
42740449PubTator, text miningPubMed
42721456PubTator, text miningPubMed

The same record as JSON

Release gene-search-2026-11-11-0.1.0

ClinicalTrials.gov's posted results, through CTTI's AACT: ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299 ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

ChEMBL, through Open Targets: CC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence

ClinicalTrials.gov: none stated ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

EMBL-EBI's patent proteins: EMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use

GenBank's patent files: GenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/

HGNC: CC0: https://www.genenames.org/about/license/

NCBI Gene: None named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/

NIH's project files and grant-paper links: Public domain (NIH RePORTER)

Open Targets: CC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence

PubTator 3: Public domain

UniProt: CC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license